3Chung SS, Blackshear JL, Shen WK, et al. Epidemiology and natund history of atrial fibrillation clinical implications[ J]. J Am Coll Cardiol,2001,37 (2) :371-378.
4Brains P,Te Velthuis H,Yazdanbakhsh AP,et al. Activation of the corm plement system during and after cardiopulmonary bypass surgery:postsurgery activation involves C-reactive protein and is associated with postoperative anhythmia[ J]. Circulation,1997,9(10) :3 542-3 548.
5Chung MK,Martin DO,Sprecher D ,et al. C-reactive protein elevation in patients with atrial anhythmias:inflammatory mechanisms and persistence of atrial fibrillation[J]. Criculation,2001,104(24) :2 886 -2 891.
6Dernellis J,Panareton M. C-reactive protein and paroxysmal atrial fibrillation:evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation[J]. Acta Cardiol,2001,56(6) :375 -380.
7Aviles RJ, Martin DO, Apperaon Hansen C, et al. Inflammation as a risk factor for atrial fibrillation [ J ]. Circulation, 2003, 108 ( 24 ) : 3 006 -3 010.
8Ustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation [ J ]. Circulation, 1997, 96(4) :1 180 -1 184.
9Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy C-reactlve protein attenuates nitric oxide production and inhibits angiogenesis [J]. Circulation,2002,106(8) :913 -919.
10Shiroshita-Takeshita A, Brundel B J, Lavoie J, et al. Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs[ J ]. Cardiovasc Res,2006,69 (4) : 865 - 875.
